Cardeation Capital expands health care innovation in heart disease and stroke care
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Cardeation Capital expands health care innovation in heart disease and stroke care
heart.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heart.org Daily Mail and Mail on Sunday newspapers.
Moving Analytics Raises $6M to Increase Virtual Cardiac Rehab Solutions and Expand Team Amidst Telehealth Industry Growth
Share Article
With this round, the company will be able to grow their partner and customer base, increasing enrollment rates and clinical outcomes across the country.
Moving Analytics Virtual Cardiac Rehab
Through our extensive due diligence and vetting through our partners, we have found Movn to be the most comprehensive and mature solution in the market with stellar proof points and evidence of success. LOS ANGELES (PRWEB) April 19, 2021
Moving Analytics, a telehealth company providing virtual cardiac rehab solutions, today announced it raised $6M in a Series Seed-2 round. The round was led by Aphelion Capital, LLC, through Cardeation Capital, with co-investments by OCA Ventures and Seae Ventures. This investment brings Moving Analytics’ total funding received to date to $9.5M.
MIVI Neuroscience Secures Series B Funding
News provided by
Share this article
Share this article
EDEN PRAIRIE, Minn., Jan. 21, 2021 /PRNewswire/ MIVI Neuroscience, a medical device company focused on improving clinical outcomes for ischemic stroke patients, today announced the closing of its Series B funding including $35 million in new money plus the conversion of previously issued convertible notes. The funding was led by a major multinational med-tech company and included participation from new investors Perceptive Advisors, Deerfield Management and Aphelion / Cardeation Capital as well as existing investors including Concord Health Partners. Raymond James & Associates, Inc. acted as sole placement agent for the transaction.